{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:18:27Z","timestamp":1787386707526,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.wneu.2020.06.017","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T21:05:33Z","timestamp":1591650333000},"page":"e778-e782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Personal and Familial Malignancy History in Patients with Malignant Peripheral Nerve Sheath Tumors with a Focus on Sporadic Tumors"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-2068","authenticated-orcid":false,"given":"Courtney","family":"Pendleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Everson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-245X","authenticated-orcid":false,"given":"Ross C.","family":"Puffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-7763","authenticated-orcid":false,"given":"Robert J.","family":"Spinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.06.017_bib1","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.06.017_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.wneu.2017.06.010","article-title":"Radiation-induced malignant peripheral nerve sheath tumors: a systematic review","volume":"105","author":"Yamanaka","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2020.06.017_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jso.22122","article-title":"Post-radiation sarcomas. Clinical outcome of 52 patients","volume":"105","author":"Mavrogenis","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.wneu.2020.06.017_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-013-1209-3","article-title":"Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis","volume":"127","author":"Brosius","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2020.06.017_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","article-title":"Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST","volume":"40","author":"Prieto-Granada","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2020.06.017_bib6","doi-asserted-by":"crossref","first-page":"8685638","DOI":"10.1155\/2017\/8685638","article-title":"SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 associated chemotherapy-naive malignant peripheral nerve sheath tumors","volume":"2017","author":"Higham","year":"2017","journal-title":"Sarcoma"},{"key":"10.1016\/j.wneu.2020.06.017_bib7","doi-asserted-by":"crossref","first-page":"7656747","DOI":"10.1155\/2019\/7656747","article-title":"Targeting sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST) in a phase II study of everolimus in combination with bevacizumab (SARC016)","volume":"2019","author":"Widemann","year":"2019","journal-title":"Sarcoma"},{"key":"10.1016\/j.wneu.2020.06.017_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11060-012-0852-1","article-title":"Overactivation of Ras signaling pathway in CD133+ MPNST cells","volume":"108","author":"Borrego-Diaz","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.06.017_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1215\/15228517-2008-127","article-title":"Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors","volume":"11","author":"Brekke","year":"2009","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2020.06.017_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/path.2633","article-title":"Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours","volume":"220","author":"Subramanian","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.wneu.2020.06.017_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-62702-5.00004-4","article-title":"Neurofibromatosis type 1","volume":"132","author":"Anderson","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.wneu.2020.06.017_bib12","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.wneu.2020.06.017_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/cancers12010114","article-title":"An update on neurofibromatosis type 1-associated gliomas","volume":"12","author":"Lobbous","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.wneu.2020.06.017_bib14","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1097\/MPH.0000000000001156","article-title":"Malignant peripheral nerve sheath tumors in neurofibromatosis: impact of family history","volume":"40","author":"Malbari","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.wneu.2020.06.017_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41391-018-0089-y","article-title":"Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer","volume":"22","author":"Chattopadhyay","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.wneu.2020.06.017_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/ijc.30583","article-title":"Concordant and discordant familial cancer: familial risks, proportions and population impact","volume":"140","author":"Frank","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2020.06.017_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/s12885-019-6055-9","article-title":"First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.wneu.2020.06.017_bib18","doi-asserted-by":"crossref","first-page":"e0215453","DOI":"10.1371\/journal.pone.0215453","article-title":"Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia\u2014a single center analysis","volume":"14","author":"Sandner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2020.06.017_bib19","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.1038\/s41598-018-28819-7","article-title":"Familial associations in testicular cancer with other cancers","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2020.06.017_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/fampra\/12.3.287","article-title":"The prevalence of a family history of cancer in general practice","volume":"12","author":"Johnson","year":"1995","journal-title":"Fam Pract"},{"key":"10.1016\/j.wneu.2020.06.017_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000294469","article-title":"Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study","volume":"13","author":"Mai","year":"2010","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.wneu.2020.06.017_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/0284186X.2017.1404635","article-title":"Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer","volume":"57","author":"Augustinsson","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.wneu.2020.06.017_bib23","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1002\/cam4.1210","article-title":"Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer","volume":"6","author":"Campacci","year":"2017","journal-title":"Cancer Med"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020312754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020312754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:51:09Z","timestamp":1761814269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020312754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"alternative-id":["S1878875020312754"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.06.017","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personal and Familial Malignancy History in Patients with Malignant Peripheral Nerve Sheath Tumors with a Focus on Sporadic Tumors","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}